Dow Jones received a payment from EQS/DGAP to publish this press release.
DGAP-Media / 2018-05-09 / 16:52
*AlzChem research uncovers new synthesis route* *for amidines*
*Trostberg. *Amidines are organic chemical compounds with an NCN structure,
meaning a typical nitrogen-carbon-nitrogen sequence. These types of
chemicals are one of AlzChem's core competencies. NCN structures are
contained in many biologically active molecules, which is why a general new
synthesis method is so important to the development and production of active
ingredients in pharmaceuticals and crop protection. Amidines to this point
have been difficult to synthesize, particularly without substituents on
nitrogen. An alternative for these cases has now been uncovered: AlzChem
research has found a new synthesis process for amidines that adds another
innovative method to the toolbox of active ingredient chemistry.
This new, previously unknown synthesis pathway developed from the foundation
of AlzChem's intelligent combination of three areas of expertise - global
technology leadership in NCN chemistry, decades of expertise in the
synthesis of organomagnesium Grignard compounds and know-how in silane
reactions:
"Our innovative process will especially interest the pharmaceutical
industry," explains Ulli Seibel, Chairman of the Management Board of AlzChem
Group AG. "It also holds considerable potential for our growing Specialty
Chemicals business segment, which already accounts for nearly 60 percent of
our sales."
The new method was published in the renowned scientific journal SYNLETT
(Issue 2017; 28(12): 1437-1440); patents are pending.
*About AlzChem Group AG*
AlzChem Group AG is a vertically integrated manufacturer of various chemical
products based on the NCN chain. These are products with typical
nitrogen-carbon-nitrogen bonding that are used in a wide variety of
different industries. The company has a leading position in select niche
markets, including the markets for feed additives and food supplements. The
strategic focus of growth and the main focus of its extensive research and
development are on the business segment Specialty Chemicals. The company has
around 1,500 employees at four sites in Germany and three other sites
abroad.
End of Media Release
Issuer: AlzChem Group AG
Key word(s): Research/Technology
2018-05-09 Dissemination of a Press Release, transmitted by DGAP - a service
of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: ir@alzchem.com
Internet: www.alzchem.com
ISIN: DE000A0AHT46
WKN: A0AHT4
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Stuttgart
End of News DGAP Media
684515 2018-05-09
(END) Dow Jones Newswires
May 09, 2018 10:51 ET (14:51 GMT)
